Publications

Found 4 results
Filters: Keyword is Trypanosomiasis, African and Author is S Muyldermans  [Clear All Filters]
2012
Caljon, G., V. Caveliers, T. Lahoutte, B. Stijlemans, G. H. Ghassabeh, J. Van Den Abbeele, I. Smolders, P. De Baetselier, Y. Michotte, S. Muyldermans, et al., "Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.", Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.
2011
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
2006
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.", Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].", Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.